# Label-free cell signaling pathway deconvolution of Angiotensin type 1 receptor reveals time-resolved G-protein activity and distinct AngII and AngIII\IV responses

## TL;DR

This study uses label-free surface plasmon resonance to analyze real-time G protein signaling pathways activated by the AT1R receptor, revealing distinct ligand-specific response signatures and pathway contributions.

## Contribution

It introduces a novel SPR-based method to deconvolute cell signaling pathways of AT1R, providing detailed time-resolved responses for various ligands and pathways.

## Key findings

- G12 plays a major role in early AT1R responses
- ERK1/2 contributes to later signaling phases
- Endogenous ligands show distinct response signatures

## Abstract

Angiotensin II (AngII) type 1 receptor (AT1R) is a G protein-coupled receptor known for its role in numerous physiological processes and its implication in many vascular diseases. Its functions are mediated through G protein dependent and independent signaling pathways. AT1R has several endogenous peptidic agonists, all derived from angiotensinogen, as well as several synthetic ligands known to elicit biased signaling responses. Here, surface plasmon resonance (SPR) was used as a cell- based and label-free technique to quantify, in real time, the response of HEK293 cells stably expressing the human AT1R. The goal was to take advantage of the integrative nature of this assay to identify specific signaling pathways in the features of the response profiles generated by numerous endogenous and synthetic ligands of AT1R. First, we assessed the contributions of Gq, G12/13, Gi, Gbg, ERK1/2 and \b{eta}- arrestins pathways in the cellular responses measured by SPR where Gq, G12/Rho/ROCK together with \b{eta}-arrestins and ERK1/2 were found to play significant roles. More specifically, we established a major role for G12 in the early events of the AT1R-dependent response, which was followed by a robust ERK1/2 component associated to the later phase of the signal. Interestingly, endogenous AT1R ligands (AngII, AngIII and AngIV) exhibited distinct responses signatures with a significant increase of the ERK1/2-like components for both AngIII and AngIV, which points toward possibly distinct physiological roles for the later. We also tested AT1R biased ligands, all of which affected both the early and later events. Our results support SPR-based integrative cellular assays as a powerful approach to delineate the contribution of specific signaling pathways for a given cell response and reveal response differences associated with ligands with distinct pharmacological properties.

---
Source: https://tomesphere.com/paper/1903.10946